Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study

Pellanda, Alessandra; De Bari, Berardino; Deniaud-Alexandre, Elisabeth; Krengli, Marco; Van Houtte, Paul; Richetti, Antonella; Villa, Salvador; Goldberg, Hadassah; Szutowicz-Zielinska, Ewa; Bolla, Michel; Rutten, Heidi; Van Eijkeren, Marc; Poortmans, Philip; Henke, Guido; Anacak, Yavuz; Chan, Steve; Landmann, Christine; Kirkove, Carine; Scandolaro, Luciano; Bernier, Jacques; Mirimanoff, Rene-Olivier; Ozsahin, Mahmut

doi:10.21147/j.issn.1000-9604.2017.06.06

Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study

Pellanda A. F., De Bari B., Deniaud-Alexandre E., Krengli M., Van Houtte P., Richetti A., ...Daha Fazla

CHINESE JOURNAL OF CANCER RESEARCH, cilt.29, sa.6, ss.521-532, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 29 Sayı: 6
Basım Tarihi: 2017
Doi Numarası: 10.21147/j.issn.1000-9604.2017.06.06
Dergi Adı: CHINESE JOURNAL OF CANCER RESEARCH
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.521-532
Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Objective: Primary uterine leiomyosarcomas (ULMS) are rare, and the optimal treatment is controversial. We aimed to assess the outcome and prognostic factors in a multicenter population of women treated for primary ULMS.